Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
Clinical trial NCT01649258 · TERMINATED
Trial details
- NCT number
- NCT01649258
- Sponsor
- University of Southern California
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-04
- Primary completion
- 2017-05-22
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.